drugset / Trial / NCT04278989

Inhibition of Oral Tumorigenesis by Antitumor B

NCT04278989 ↗

Phase 0 Completed 30 enrolled Medical College of Wisconsin
NaSingle-groupOpen-labelTreatment

Summary

This is a window of opportunity study of Anti-tumor B (ATB). Anti-tumor B is a botanical agent composed of six Chinese herbs: Sophora tonkinensis, Polygonum bistorta, Prunella vulgaris, Sonchus brachyotus, Dictamnus dasycarpus, and Dioscorea bulbifera.

Timeline

Start
2022-04-22
Primary completion
2025-05-19
Completion
2025-06-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Antitumor B Traditional medicine (herbal / TCM) 1200 mg —